AR241016A2 - Carbapenem process - Google Patents

Carbapenem process

Info

Publication number
AR241016A2
AR241016A2 AR29587784A AR29587784A AR241016A2 AR 241016 A2 AR241016 A2 AR 241016A2 AR 29587784 A AR29587784 A AR 29587784A AR 29587784 A AR29587784 A AR 29587784A AR 241016 A2 AR241016 A2 AR 241016A2
Authority
AR
Argentina
Prior art keywords
nitrogen
substituted
alkylene
group
atom
Prior art date
Application number
AR29587784A
Other languages
Spanish (es)
Other versions
AR241016A1 (en
Original Assignee
Bristol Myeres Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myeres Squibb Company filed Critical Bristol Myeres Squibb Company
Application granted granted Critical
Publication of AR241016A2 publication Critical patent/AR241016A2/en
Publication of AR241016A1 publication Critical patent/AR241016A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)

Abstract

COMPUESTOS DE AMINOTIOL CUATERNARIOS, CARACTERIZADOS PORQUE RESPONDEN A LA FORMULA (VII), EN DONDE:AREPRESENTA UN GRUPO CICLOPENTILENO,CICLOHEXILENO, ALQUILENO O ALQUILENO SUBSTITUIDO POR UN GRUPO ALQUILO; X ES UN CONTRAANION; Y R14 COMPRENDE A UN RADICAL HETEROCICLICO QUE CONTIENE POR LO MENOS UN ATOMO DE NITROGENO EN EL ANILLO Y UNIDO AL GRUPO A MEDIANTE UN ATOMO DE NITROGENO DE LANILLO, FORMANDO UN ATOMO DE NITROGENO CUATERNIZADO, ESTANDO EL RADICAL HETEROCICLICO CUATERNIZADO ELEGIDO ENTRE PIRIDINO, AMIDAZOLINEO CON O MORFOLINO SUBSTITUIDO ONO.QUATERNARY AMINOTIOL COMPOUNDS, CHARACTERIZED BECAUSE THEY RESPOND TO FORMULA (VII), WHERE: ARE PRESENTING A CYCLOPHENYLENE, ALKYLENE OR ALKYLENE GROUP SUBSTITUTED BY AN ALKYL GROUP; X IS A COUNTERANION; AND R14 INCLUDES A HETERO CYCLIC RADICAL CONTAINING AT LEAST ONE NITROGEN ATOM IN THE RING AND JOINED THE GROUP THROUGH A LANILLO NITROGEN NEGROGEN ATOM, CONTAINING A NARROCHENE-NITROGEN, NARROID OR MORFOLINO SUBSTITUTED ONO.

AR295877A 1983-03-08 1984-02-29 "QUATERNARY AMINOTIOL DERIVATIVES, PROCEDURE TO PREPARE THEM AND PROCEDURE TO PREPARE CARBAPENEM COMPOUNDS FROM THESE DERIVATIVES". AR241016A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47137883A 1983-03-08 1983-03-08
US49969183A 1983-06-07 1983-06-07
US55729583A 1983-12-01 1983-12-01

Publications (2)

Publication Number Publication Date
AR241016A2 true AR241016A2 (en) 1991-04-30
AR241016A1 AR241016A1 (en) 1991-04-30

Family

ID=27413179

Family Applications (1)

Application Number Title Priority Date Filing Date
AR295877A AR241016A1 (en) 1983-03-08 1984-02-29 "QUATERNARY AMINOTIOL DERIVATIVES, PROCEDURE TO PREPARE THEM AND PROCEDURE TO PREPARE CARBAPENEM COMPOUNDS FROM THESE DERIVATIVES".

Country Status (31)

Country Link
JP (1) JPH05255250A (en)
KR (1) KR900002247B1 (en)
AR (1) AR241016A1 (en)
AT (1) AT387968B (en)
AU (2) AU572124B2 (en)
CA (1) CA1284324C (en)
CH (1) CH658248A5 (en)
CY (1) CY1546A (en)
DD (1) DD228258A5 (en)
DE (1) DE3408347A1 (en)
DK (1) DK140584A (en)
ES (2) ES8505205A1 (en)
FI (1) FI840863A (en)
FR (1) FR2542316B1 (en)
GB (1) GB2136802B (en)
GR (1) GR81871B (en)
HK (1) HK82990A (en)
HU (1) HU193895B (en)
IE (1) IE57098B1 (en)
IL (1) IL71149A (en)
IT (1) IT1178465B (en)
LU (1) LU85241A1 (en)
NL (1) NL8400702A (en)
NO (1) NO166038C (en)
NZ (1) NZ207346A (en)
OA (1) OA07674A (en)
PT (1) PT78211B (en)
SE (2) SE8401278L (en)
SG (1) SG35490G (en)
YU (2) YU46147B (en)
ZW (1) ZW3884A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683301A (en) * 1982-04-08 1987-07-28 Bristol-Myers Company Carbapenem antibiotics
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
IE851586L (en) * 1984-07-02 1986-01-02 Interchem Internat S A I methylcarbapenems having a 2-quaternary¹heteroarylalkylthio substituent
CA1285940C (en) * 1984-07-02 1991-07-09 Merck & Co., Inc. Carbapenems having a 2-quaternary heteroarylalkylthio substituent
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4880922A (en) * 1985-11-22 1989-11-14 Bristol-Myers Company Carbapenems with quaternized heterothioalkylthio substitution at position 2
NZ219892A (en) * 1986-04-15 1991-02-26 Merck & Co Inc N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof
IE910606A1 (en) * 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
US5712267A (en) * 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
CA2526209A1 (en) 2003-06-12 2004-12-23 Btg International Limited Cyclic hydroxylamine as psychoactive compounds
FR2921258A1 (en) * 2007-09-24 2009-03-27 Oreal TINCTORIAL COMPOSITION COMPRISING AT LEAST ONE COLOR DISULFIDE / THIOL PRECURSOR, COLORING PROCESS FROM THE COMPOSITION

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55147284A (en) * 1979-04-17 1980-11-17 Sanraku Inc Novel beta-lactam derivative and its preparation
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
EP0038869A1 (en) * 1980-04-30 1981-11-04 Merck & Co. Inc. Process for the preparation of 1-carbapenems, and intermediates for their preparation
EP0060612A1 (en) * 1981-02-04 1982-09-22 Beecham Group Plc Process for the preparation of azabicyclo(3.2.0)-hept-2-ene derivatives
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
EP0074599A1 (en) * 1981-09-09 1983-03-23 Takeda Chemical Industries, Ltd. 5,6-cis-Carbapenem derivatives, their production and use
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics

Also Published As

Publication number Publication date
IT8419945A0 (en) 1984-03-07
HUT34980A (en) 1985-05-28
DK140584D0 (en) 1984-02-29
IL71149A (en) 1990-03-19
SE8901162D0 (en) 1989-04-03
DK140584A (en) 1984-09-09
YU49486A (en) 1987-12-31
IE840549L (en) 1984-09-08
AT387968B (en) 1989-04-10
FR2542316A1 (en) 1984-09-14
AU7592487A (en) 1987-10-22
KR840008157A (en) 1984-12-13
IT1178465B (en) 1987-09-09
ES537349A0 (en) 1985-08-16
HU193895B (en) 1987-12-28
PT78211B (en) 1986-08-12
IE57098B1 (en) 1992-04-22
SG35490G (en) 1990-07-13
CA1284324C (en) 1991-05-21
YU42084A (en) 1986-08-31
IL71149A0 (en) 1984-06-29
CY1546A (en) 1991-03-22
ES8507145A1 (en) 1985-08-16
ZW3884A1 (en) 1984-10-10
DD228258A5 (en) 1985-10-09
AU2536084A (en) 1984-09-13
YU46147B (en) 1993-05-28
DE3408347A1 (en) 1984-09-13
JPH05255250A (en) 1993-10-05
FR2542316B1 (en) 1988-10-07
AU572124B2 (en) 1988-05-05
SE8401278D0 (en) 1984-03-07
NL8400702A (en) 1984-10-01
PT78211A (en) 1984-04-01
GR81871B (en) 1984-12-12
CH658248A5 (en) 1986-10-31
NO166038B (en) 1991-02-11
KR900002247B1 (en) 1990-04-07
OA07674A (en) 1985-05-23
NO166038C (en) 1991-05-22
ES530337A0 (en) 1985-05-16
FI840863A0 (en) 1984-03-05
LU85241A1 (en) 1984-11-14
HK82990A (en) 1990-10-19
NZ207346A (en) 1987-01-23
GB2136802B (en) 1987-05-20
ATA76984A (en) 1988-09-15
AU605491B2 (en) 1991-01-17
SE8901162L (en) 1989-04-03
FI840863A (en) 1984-09-09
YU46305B (en) 1993-05-28
GB2136802A (en) 1984-09-26
NO840865L (en) 1984-09-10
SE8401278L (en) 1984-09-09
ES8505205A1 (en) 1985-05-16
GB8405984D0 (en) 1984-04-11
AR241016A1 (en) 1991-04-30

Similar Documents

Publication Publication Date Title
EG15458A (en) Improvements in or relating to 3-aryloxy-3-phenylpropylamines
AR245705A1 (en) Improvements in or relating to leukotriene antagonists
ES2036551T3 (en) HETERO CYCLIC COMPOUNDS.
BE838783A (en) RAPID CRYSTALLIZATION POLY (ETHYLENE / ALKYLENE TEREPHTHALATES)
AR241016A2 (en) Carbapenem process
DE3779461T2 (en) SUBSTITUTED BY POLYSACCHARID'S ALKYL GROUPS.
FR2301546A1 (en) RAPID CRYSTALLIZATION POLY (ETHYLENE / ALKYLENE TEREPHTHALATES)
IT1138364B (en) ACTIVATION CLOSURE BY VIAL
KR840005101A (en) Method for preparing 2-quinoline derivative
IT8023163A0 (en) PROCESS FOR THE PREPARATION OF ORGANIC CARBOXYLATED COMPOUNDS.
DE68917099T2 (en) Production of secondary aliphatic amines.
IT1088920B (en) RUBBER COMPOUND FOR HERMETIC CLOSURE OF JAR BOTTLES
DE3771087D1 (en) METHOD FOR WOOD PROTECTION.
GB8531160D0 (en) Organic compounds
IT7831352A0 (en) PROCESS FOR THE ALKYLATION OF 4(5)-MERCAPTOMETHYL-IMIDAZOLES WITH AZIRIDINE DERIVATIVES.
JPS52118405A (en) Novel polyamines
EP0148953A4 (en) 7-fluoroprostaglandins and process for their preparation.
IT1149846B (en) PROCESS FOR THE SYNTHESIS OF 1-AMINO-3-P (B-METOXY-ETHYL) -PHENOSIS-2-PROPANOL
MX150832A (en) IMPROVEMENTS TO A BOTTLE CARRIER
AU546025B2 (en) Agent for detecting ketone-bodies
JPS52122358A (en) Novel methano-anthracene derivatives
SE8306298D0 (en) 7beta-ISOTIAZOLYLTIOACETAMIDO-7alpha-METOXICEFALOSPORANSYRADERIVAT
JPS52106848A (en) Cyclopropenone and cyclopenthione derivatives and their preparation
JPS51125373A (en) A process for preparing novel methano-anthracene derivatine
ES476150A1 (en) Preparation of N-chloroimides and a novel N-chloroimide.